IQVIA selects Veeva clinical operations applications

On Oct. 13, IQVIA announced it selected Veeva Clinical Operations applications for clinical development studies. Veeva’s shares rose 2.8% that afternoon, according to StockStory; the available report did not give IQVIA’s or CRO peers’ reaction.